-
Venetoclax Elicits Immune Synapse Repair in Chronic Lymphocytic Leukemia
07 Feb 2025 19:09 GMT
… immune synapses in patients with chronic lymphocytic leukemia (CLL) via complex, multifaceted mechanisms … evaluation of immunologic changes in chronic lymphocytic leukemia with venetoclax treatment. Blood. 2024 …
-
CLL Treatment Advances and Frontline Therapy Insights With Dr. Khan
07 Feb 2025 23:54 GMT
… , discusses how treatment paradigms for chronic lymphocytic leukemia (CLL) have changed in recent …
-
REGENCY: Obinutuzumab Proves Efficacy in Lupus Nephritis
07 Feb 2025 14:06 GMT
… combination treatment of patients with chronic lymphocytic leukemia and follicular lymphoma dating back …
-
“All-Tablet” Treatment Shows Promise for Common Form of Leukemia
07 Feb 2025 10:36 GMT
… -duration acalabrutinib combinations in untreated chronic lymphocytic leukemia. N Engl J Med. 2025 …
-
New England Journal of Medicine Publishes New Data for Genentech’s Gazyva Which Shows Superiority Over Standard Therapy in People With Active Lupus Nephritis
07 Feb 2025 08:52 GMT
… chemotherapy drug, chlorambucil, to treat chronic lymphocytic leukemia (CLL) in adults who have …
-
NX-5948 Demonstrates Preliminary Efficacy in High-Risk CLL
06 Feb 2025 23:50 GMT
… early efficacy in patients with chronic lymphocytic leukemia (CLL), positioning it as a … /refractory (R/R) chronic lymphocytic leukemia (CLL): updated results from an …
-
Personalized CLL Therapy With MRD Guidance Improves Survival Outcomes
06 Feb 2025 21:58 GMT
Tailoring chronic lymphocytic leukemia (CLL) treatment based on measurable … DA, Bloor A, et al. Chronic lymphocytic leukemia therapy guided by measurable residual …
-
Roferon A Global Market Report 2025 predicts remarkable advancements and growth
06 Feb 2025 17:28 GMT
… ;leukemia-therapeutics-global-market-report
Chronic Lymphocytic Leukemia Treatment Global Market Report 2025 … .thebusinessresearchcompany.com/report/chronic-lymphocytic-leukemia-treatment-global-market-report
About …
-
Genetic and Plasma Proteomic Approaches to Identify Therapeutic Targets for Graves’ Disease and Graves’ Ophthalmopathy
06 Feb 2025 17:10 GMT
… .35 In multiple myeloma and chronic lymphocytic leukemia, two diseases that are closely …
-
Lilly Reports 45% Increase in Q4 2024 Financial Results - Provides 2025 Guidance
06 Feb 2025 16:13 GMT
… ) inhibitor in adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL …